BeyondSpring
BYSI • NASDAQ
BeyondSpring is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Lan Huang, with a market cap of $65.8M.
CEOLan Huang
Next Earnings
Upcoming earnings announcement for BeyondSpring
Date
Monday, May 11, 2026 (in a month)
Timing
After Market Close (5:00 PM New York)
Fiscal Period
Q1 2026
Earnings History
Past 12 earnings reports for BeyondSpring
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 25, 2026 | Q4 2025 | -$0.05 | — | - | — | — |
| Nov 12, 2025 | Q3 2025 | -$0.04 | — | - | — |  10-Q |
| Aug 13, 2025 | Q2 2025 | -$0.04 | — | - | — | 10-Q |
| May 12, 2025 | Q1 2025 | -$0.06 | — | - | — | 10-Q |
| Apr 14, 2022 | Q4 2021 | -$0.24Est: -$0.26 | +7.7% | $338.0K | — | — |
| Dec 30, 2021 | Q3 2021 | -$0.47Est: -$0.58 | +19.0% | $337.0KEst: $340.0K | -0.9% | — |
| Sep 10, 2021 | Q2 2021 | -$0.49Est: -$0.48 | -2.1% | $338.0KEst: $8.8M | -96.1% | — |
| Jun 16, 2021 | Q1 2021 | -$0.44Est: -$0.54 | +18.5% | $338.0K | — | — |
| Apr 30, 2021 | Q4 2020 | -$0.52Est: -$0.57 | +8.8% | $180.0K | — | — |
| Nov 17, 2020 | Q3 2020 | -$0.48Est: -$0.54 | +11.1% | - | — | — |
| Sep 3, 2020 | Q2 2020 | -$0.46Est: -$0.57 | +19.3% | - | — | — |
| Jun 11, 2020 | Q1 2020 | -$0.58Est: -$0.46 | -26.1% | - | — | — |